Fine particle mass from the Diskus inhaler and Turbuhaler inhaler in children with asthma

The study aimed to investigate dose consistency and particle distribution from the dry powder inhalers Diskus and Turbuhaler. Full profiles of inhalation pressure versus time were recorded in 18 4 yr old and 18 8 yr old asthmatic children through Diskus and Turbuhaler inhalers. These data were used in an inhalation profile simulator to assess drug delivery from both a Diskus inhaler and a Turbuhaler inhaler, and in particular to assess the proportion of drug emitted in the coarse (>4.7 microm) and fine (<4.7 microm) particle size range from each type of inhaler. The inhalation profile more accurately represents the changes in flow rate over time through the device than the constant flow rate usually applied with an impactor alone. The aerosol cloud was released before the peak inspiratory effort had been achieved and accordingly the early part and not the peak of the inspiratory performance is a determinant of the quality of the aerosol. The mean (SD) amount of drug in large particles (>4.7 microm), fine particles (<4.7 microm) and very fine particles (<2.1 microm) in percentage of label claim from the Fluticasone Diskus was 72 (5), 15 (2) and 2 (1) from the 4 yr old children and 71 (3), 18 (2) and 2 (1) from the 8 yr old children, respectively. Similar particle fractions from the Budesonide Turbuhaler were 35 (9), 21 (10) and 7 (5) from 4 yr old children and 30 (7), 32 (9) and 12 (6) from 8 yr old children. In conclusion, the Diskus inhaler provides an improved dose consistency through the varying age groups and inspiratory flow performances when compared to the Turbuhaler in terms of the proportion of the dose emitted at each particle size. This improvement is at the expense of a low fine particle mass and a high proportion of coarse particles from the Diskus as compared with the Turbuhaler.

This article has been cited by other articles:

				W. Janssens, P. VandenBrande, E. Hardeman, E. De Langhe, T. Philps, T. Troosters, and M. Decramer Inspiratory flow rates at different levels of resistance in elderly COPD patients Eur. Respir. J., January 1, 2008; 31(1): 78 - 83. [Abstract] [Full Text] [PDF]

				Inhalation devices Can. Med. Assoc. J., September 13, 2005; 173(6_suppl): S39 - S45. [Full Text] [PDF]

				B. K. Rubin What Does It Mean When a Patient Says, "My Asthma Medication Is Not Working?" Chest, September 1, 2004; 126(3): 972 - 981. [Full Text] [PDF]

				L. Agertoft and S. Pedersen Lung Deposition and Systemic Availability of Fluticasone Diskus and Budesonide Turbuhaler in Children Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 779 - 782. [Abstract] [Full Text] [PDF]

				T W Harrison and A E Tattersfield Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects Thorax, March 1, 2003; 58(3): 258 - 260. [Abstract] [Full Text] [PDF]

				J. Price, P. Hindmarsh, S. Hughes, and J. Efthimiou Evaluating the effects of asthma therapy on childhood growth: principles of study design Eur. Respir. J., June 1, 2002; 19(6): 1167 - 1178. [Abstract] [Full Text] [PDF]

				B J LIPWORTH, T HARRISON, A TATTERSFIELD, S A MCKENZIE, T HARRISON, and A TATTERSFIELD Systemic effects of inhaled steroids Thorax, December 1, 2001; 56(12): 980b - 981. [Full Text] [PDF]

				M.E.A.C. Broeders, J. Molema, N.A. Vermue, and H.Th.M. Folgering Peak inspiratory flow rate and slope of the inhalation profiles in dry powder inhalers Eur. Respir. J., November 1, 2001; 18(5): 780 - 783. [Abstract] [Full Text] [PDF]

				L FABBRI and R MELARA Systemic effects of inhaled corticosteroids are milder in asthmatic patients than in normal subjects Thorax, March 1, 2001; 56(3): 165 - 166. [Full Text]

				J. A. ØJ, L. THORSSON, and H. BISGAARD Lung Deposition of Inhaled Drugs Increases with Age Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1819 - 1822. [Abstract] [Full Text]

				S. Kannisto, M. Korppi, K. Remes, and R. Voutilainen Adrenal Suppression, Evaluated by a Low Dose Adrenocorticotropin Test, and Growth in Asthmatic Children Treated with Inhaled Steroids J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 652 - 657. [Abstract] [Full Text]